RDTCF (Rapid Dose Therapeutics) Total Assets: $2.41 Mil (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RDTCF Rapid Dose Therapeutics Corp RDTCF
29 GF Score
Price $0.08
GF Value $0.22
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Rapid Dose Therapeutics Total Assets?

Rapid Dose Therapeutics RDTCF 29 Total Assets is $2.41 Mil as of Feb. 2026. GuruFocus rates RDTCF with a GF Score™ of 29/100 and a GF Value™ of $0.22 (Possible Value Trap). The stock has 3 warning signs investors should review.

Rapid Dose Therapeutics's Total Assets for the quarter that ended in Feb. 2026 was $2.41 Mil.

During the past 12 months, Rapid Dose Therapeutics's average Total Assets Growth Rate was 102.70% per year. During the past 3 years, the average Total Assets Growth Rate was 13.80% per year. During the past 5 years, the average Total Assets Growth Rate was -7.80% per year.

During the past 13 years, Rapid Dose Therapeutics's highest 3-Year average Total Assets Growth Rate was 362.60%. The lowest was -56.70%. And the median was -9.95%.

Total Assets is connected with ROA %. Rapid Dose Therapeutics's annualized ROA % for the quarter that ended in Feb. 2026 was -80.45%. Total Assets is also linked to Revenue through Asset Turnover. Rapid Dose Therapeutics's Asset Turnover for the quarter that ended in Feb. 2026 was 0.19.

Rapid Dose Therapeutics  (OTCPK:RDTCF) Total Assets Explanation

Total Assets is connected with ROA %.

Rapid Dose Therapeutics's annualized ROA % for the quarter that ended in Feb. 2026 is

ROA %=Net Income (Q: Feb. 2026 )/( (Total Assets (Q: Nov. 2025 )+Total Assets (Q: Feb. 2026 ))/ count )
=-2.052/( (2.696+2.405)/ 2 )
=-2.052/2.5505
=-80.45 %

Note: The Net Income data used here is four times the quarterly (Feb. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Rapid Dose Therapeutics's Asset Turnover for the quarter that ended in Feb. 2026 is

Asset Turnover
=Revenue (Q: Feb. 2026 )/( (Total Assets (Q: Nov. 2025 )+Total Assets (Q: Feb. 2026 ))/ count )
=0.484/( (2.696+2.405)/ 2 )
=0.484/2.5505
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Rapid Dose Therapeutics Total Assets Related Terms

Rapid Dose Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Rapid Dose Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics Total Assets Chart

Rapid Dose Therapeutics Annual Data
Trend Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.41 1.67 1.40 1.14 2.41

Rapid Dose Therapeutics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.14 2.88 3.08 2.70 2.41
RDTCF
29GF Score
Rapid Dose Therapeutics Corp RDTCF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rapid Dose Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Rapid Dose Therapeutics's Total Assets for the fiscal year that ended in Feb. 2026 is calculated as

Total Assets=Total Equity (A: Feb. 2026 )+Total Liabilities (A: Feb. 2026 )
=-5.257+7.663
=2.41

Rapid Dose Therapeutics's Total Assets for the quarter that ended in Feb. 2026 is calculated as

Total Assets=Total Equity (Q: Feb. 2026 )+Total Liabilities (Q: Feb. 2026 )
=-5.257+7.663
=2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $2.41 Mil mean?
Rapid Dose Therapeutics (RDTCF) has a Total Assets of $2.41 Mil as of Feb. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Rapid Dose Therapeutics and its competitors.
Is Rapid Dose Therapeutics' Total Assets too high?
Rapid Dose Therapeutics' current Total Assets is $2.41 Mil. Overall, Rapid Dose Therapeutics has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rapid Dose Therapeutics' Total Assets compare to VRTX and REGN?
Rapid Dose Therapeutics' Total Assets of $2.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Rapid Dose Therapeutics and its competitors. Rapid Dose Therapeutics's current Total Assets is $2.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Dose Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.22, compared to a current price of $0.08 — trading 64.3% below its estimated fair value. The current Total Assets is $2.41 Mil. Rapid Dose Therapeutics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current Total Assets is $2.41 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rapid Dose Therapeutics (RDTCF) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Dose Therapeutics stock appears to be undervalued. The current stock price of $0.08 is trading 64.3% below its estimated GF Value™ of $0.22. GuruFocus considers Rapid Dose Therapeutics to be Possible Value Trap.

Key valuation signals for RDTCF:

  • Total Assets: $2.41 Mil
  • GF Value™: $0.22 vs. price of $0.08 (64.3% below fair value)
  • GF Score™: 29/100 with 3 warning signs

No single metric tells the full story. See the RDTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rapid Dose Therapeutics Business Description

Other Exchanges DOSE:Canada
Address 1121 Walkers Line, Unit 3a, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
29GF Score

Get the complete analysis for RDTCF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.22
GF Value